|
2023
|
Invention
|
Treatment of glioblastoma. Methods of treating glioblastoma are provided comprising: administerin... |
|
|
Invention
|
Treatment of immunologically cold solid tumors. In a first aspect, methods of treating glioblasto... |
|
|
Invention
|
Treatment of glioblastoma.
Methods of treating glioblastoma are provided comprising: administeri... |
|
|
G/S
|
Pharmaceuticals; Pharmaceutical preparations for the treatment of cancer and other serious illnes... |
|
|
G/S
|
Pharmaceuticals, namely, Receptor for Advanced Glycation End products (RAGE) inhibitors for the t... |
|
2022
|
Invention
|
Treatment of immunologically cold solid tumors. Methods of treating glioblastoma, and grade I, gr... |
|
2021
|
Invention
|
Treatment of myelosuppression.
Methods are presented for attenuating myelosuppressive side effec... |
|
|
Invention
|
Treatment of acute myeloid leukemia with hypomethylating agents and 2-o, 3-o desulfated heparinoi... |
|
|
Invention
|
Treatment of acute lung injury. Provided herein are methods and compositions related to using 2-O... |
|
2020
|
Invention
|
Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit dosage fo... |
|
|
Invention
|
Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction... |
|
2019
|
Invention
|
Treatment of myelosuppression. Methods are presented for attenuating myelosuppressive side effect... |
|
2018
|
Invention
|
Treatment of myelodysplastic syndromes with 2-o and, or 3-o desulfated heparinoids.
Methods are ... |
|
2017
|
Invention
|
Disulfiram and copper salt dosing regimen. This application relates to methods and compositions f... |
|
|
Invention
|
Methods of treating or preventing graft-versus-host disease using hmgb1-interacting heparinoids. ... |
|
2016
|
Invention
|
Methods of treating traumatic brain injury and sequelae.
Methods and compositions are presented ... |
|
|
Invention
|
Adoptive cell transfer methods.
Methods and compositions are presented for mobilizing hematopoie... |
|
|
Invention
|
Adoptive cell transfer methods. Methods and compositions are presented for mobilizing hematopoiet... |
|
|
Invention
|
Treatment of myelodysplastic syndromes with 2-o and,or 3-o desulfated heparinoids. Methods are pr... |
|
2015
|
Invention
|
Multivalent cation formulations of partially desulfated heparins.
Multivalent cation composition... |
|
|
Invention
|
Multivalent cation formulations of partially desulfated heparins. Multivalent cation compositions... |
|
2014
|
Invention
|
Treating bacterial infections of the lung.
The present application provides methods of treating ... |
|
|
Invention
|
Treating bacterial infections of the lung. The present application provides methods of treating a... |
|
|
Invention
|
Methods of treating and preventing radiation damage.
The invention relates to methods of treatin... |
|
|
Invention
|
Methods of treating and preventing radiation damage. The invention relates to methods of treating... |
|
2012
|
Invention
|
Sensitization of cancer cells to treatment.
The present application provides methods for the tre... |
|
2008
|
Invention
|
Methods of treating acute exacerbations of chronic obstructive pulmonary disease.
The present in... |
|
2005
|
Invention
|
Use of 2-o desulfated heparin for the treatment of heparin-induced thrombocytopenia (hit) syndrom... |
|
2004
|
Invention
|
Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (... |
|
2001
|
Invention
|
Use of heparin or nonanticoagulant heparin for inhibiting apoptosis arising from ischemia perfusi... |
|
2000
|
Invention
|
Method for the prevention of apoptosis. Heparin reduces ischemia-reperfusion injury to myocardium... |
|
1997
|
Invention
|
Methods of treating asthma with o-desulfated heparin. A method for reducing asthmatic response in... |
